Back to search

Institutional Repository of Vilnius University

Effects of statin treatment on pcsk9 and ldlr levels: potential use in combinatory treatment with crispr-cas9 methodologies /

Abstract

dc:description

Cardiovascular disease remains the leading cause of death worldwide, with low-density lip-oprotein (LDL) cholesterol playing a major role in its onset and progression. Statins are the first-choice drugs for preventing cardiovascular diseases, primarily due to their effectiveness in lower-ing cholesterol levels and reducing the risk of heart attacks and strokes. This study explores the impact of lipophilic simvastatin and hydrophilic pravastatin on PCKS9 and LDLR expression, with the goal of identifying the most effective statin and the optimal concentration for the use in combination with CRISPR-Cas9 gene editing. Among the statins evaluated, the lipophilic simvas-tatin at a concentration of 25 µM demonstrated an effect on both PCSK9 and LDLR levels, with-out significantly influencing cell viability or inducing DNA damage and apoptosis. Based on these findings, 25 µM simvastatin has been selected for future combination therapy. This combination strategy may allow for lower statin doses, minimizing side effects while maintaining or even enhancing therapeutic benefits.

Degree

thesis:*
Grantor dc:publisher
Institutional Repository of Vilnius University
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Glebavičiūtė, Goda,

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
Language dc:language
eng

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Vilnius University
Base URL
epublications.vu.lt/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Glebavičiūtė, Goda,. Effects of statin treatment on pcsk9 and ldlr levels: potential use in combinatory treatment with crispr-cas9 methodologies /. Institutional Repository of Vilnius University, 2025. https://repository.vu.lt/VU:ELABAETD239024585&prefLang=en_US